Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

Bibliography

• 1  Erkan M, Kleeff J, Esposito I et al.: Loss of bnip3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene24(27),4421–4432 (2005).
  Medline CASGoogle Scholar
• 2  Fryer RA, Galustian C, Dalgelish AG: Recent advances and developments in treatment strategies against pancreatic cancer. Curr. Clin. Pharmacol.4(2),102–112 (2009).
  Medline CASGoogle Scholar
• 3  Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol. Pharm.4(6),807–818 (2007).
  Medline CASGoogle Scholar
• 4  Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ: Dietary curcumin inhibits chemotherapy-induced apoptosis in human models of human breast cancer. Cancer Res.62(13),3868–3875 (2002).
  Medline CASGoogle Scholar
• 5  Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res.23(1A),363–398 (2003).
  Medline CASGoogle Scholar
• 6  Aggarwal BB, Sung B: Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci.30(2),85–94 (2009).
  Medline CASGoogle Scholar
• 7  Cohen AN, Veena MS, Srivatsan ES, Wang MB: Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of iκβ kinase. Arch. Otolaryngol. Head Neck Surg.135(2),190–197 (2009).
  MedlineGoogle Scholar
• 8  Farombi EO, Shrotriya S, Surh YJ: Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing cox-2 and inos expression via NF-κB and AP-1. Life Sci.84(5–6),149–155 (2009).
  Medline CASGoogle Scholar
• 9  Owens DE 3rd, Peppas NA: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm.307(1),93–102 (2006).
  Medline CASGoogle Scholar
• 10  Bisht S, Feldmann G, Soni S et al.: Polymeric nanoparticle-encapsulated curcumin (“Nanocurcumin”): a novel strategy for human cancer therapy. J. Nanobiotechnology5,3 (2007).
  MedlineGoogle Scholar
• 11  Suresh D, Srinivasan K: Studies on the in vitro absorption of spice principles – curcumin, capsaicin and piperine in rat intestines. Food Chem. Toxicol.45(8),1437–1442 (2007).
  Medline CASGoogle Scholar
• 12  Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J: Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res. A86(2),300–310 (2008).
  MedlineGoogle Scholar
• 13  Sahu A, Kasoju N, Bora U: Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules9(10),2905–2912 (2008).
  Medline CASGoogle Scholar
• 14  Torchilin VP: Structure and design of polymeric surfactant-based drug delivery systems. J. Control Release73(2–3),137–172 (2001).
  Medline CASGoogle Scholar
• 15  Lavasanifar A, Samuel J, Kwon GS: Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev.54(2),169–190 (2002).
  Medline CASGoogle Scholar
• 16  Creamer LK, Plowman JE, Liddell MJ, Smith MH, Hill JP: Micelle stability: κ-casein structure and function. J. Dairy Sci.81(11),3004–3012 (1998).
  Medline CASGoogle Scholar
• 17  Park EK, Lee SB, Lee YM: Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials26(9),1053–1061 (2005).
  Medline CASGoogle Scholar
• 18  Torchilin VP: Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res.24(1),1–16 (2007).
  Medline CASGoogle Scholar
• 19  Berrada M, Serreqi A, Dabbarh F, Owusu A, Gupta A, Lehnert S: A novel non-toxic camptothecin formulation for cancer chemotherapy. Biomaterials26(14),2115–2120 (2005).
  Medline CASGoogle Scholar
• 20  Letchford K, Zastre J, Liggins R, Burt H: Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers. Colloids Surf. B Biointerfaces35(2),81–91 (2004).
  Medline CASGoogle Scholar
• 21  Mohanty AK, Dilnawaz F, Sahoo SK: A biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (ε caprolactone) copolymeric micelles loaded with etoposide as drug delivery vehicle for pancreatic cell line. Drug Delivery (2010) (In press).
  MedlineGoogle Scholar
• 22  Zhou S, Deng X, Yang H: Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials24(20),3563–3570 (2003).
  Medline CASGoogle Scholar
• 23  Bong PH: Spectral and photophysical behaviors of curcumin and curcuminoids. Bull. Korean Chem. Soc.21(1),81–86 (2000).
  CASGoogle Scholar
• 24  Chignell CF, Bilski P, Reszka KJ, Motten AG, Sik RH, Dahl TA: Spectral and photochemical properties of curcumin. Photochem. Photobiol.59(3),295–302 (1994).
  Medline CASGoogle Scholar
• 25  Khopde SM, Priyadarsini KI, Palit DK, Mukherjee T: Effect of solvent on the excited-state photophysical properties of curcumin. Photochem. Photobiol.72(5),625–631 (2000).
  Medline CASGoogle Scholar
• 26  Misra R, Acharya S, Dilnawaz F, Sahoo SK: Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(ε-caprolactone) nanoparticles. Nanomedicine (Lond.)4(5),519–530 (2009).
  CASGoogle Scholar
• 27  Acharya S, Dilnawaz F, Sahoo SK: Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials30(29),5737–5750 (2009).
  Medline CASGoogle Scholar
• 28  Sahoo SK, Ma W, Labhasetwar V: Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer112(2),335–340 (2004).
  Medline CASGoogle Scholar
• 29  Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI: Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim. Biophys. Acta1780(4),673–679 (2008).
  Medline CASGoogle Scholar
• 30  Lev-Ari S, Vexler A, Starr A et al.: Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest.25(6),411–418 (2007).
  Medline CASGoogle Scholar
• 31  Shin IG, Kim SY, Lee YM, Cho CS, Sung YK: Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J. Control Release51(1),1–11 (1998).
  Medline CASGoogle Scholar
• 32  Shuai X, Ai H, Nasongkla N, Kim S, Gao J: Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control Release98(3),415–426 (2004).
  Medline CASGoogle Scholar
• 33  Kim SY, Shin IG, Lee YM, Cho CS, Sung YK: Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J. Control Release51(1),13–22 (1998).
  Medline CASGoogle Scholar
• 34  Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K: Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res.51(12),3229–3236 (1991).
  Medline CASGoogle Scholar
• 35  Maeda H, Wu J, Sawa T, Matsumura Y, Hori K: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control Release65(1–2),271–284 (2000).
  Medline CASGoogle Scholar
• 36  Kim SY, Shin IG, Lee YM: Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and dl-lactide block copolymer as novel drug carriers. J. Control Release56(1–3),197–208 (1998).
  Medline CASGoogle Scholar
• 37  Baimark Y: Surfactant-free nanospheres of methoxy poly (ethylene glycol)-b-poly (ε-caprolactone) for controlled release of ibuprofen. J. Appl. Sci.9(12),2287–2293 (2009).
  CASGoogle Scholar
• 38  Yueying H, Yan Z, Chunhua G, Weifeng D, Meidong L: Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery. J. Mater. Sci. Mater. Med.21(2),567–574 (2010).
  MedlineGoogle Scholar
• 39  Adhikary R, Mukherjee P, Kee TW, Petrich JW: Excited-state intramolecular hydrogen atom transfer and solvation dynamics of the medicinal pigment curcumin. J. Phys. Chem. B113(15),5255–5261 (2009).
  Medline CASGoogle Scholar
• 40  Leung MH, Kee TW: Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir25(10),5773–5777 (2009).
  Medline CASGoogle Scholar
• 41  Wang YJ, Pan MH, Cheng AL et al.: Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal.15(12),1867–1876 (1997).
  Medline CASGoogle Scholar
• 42  Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN: Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci.37(3–4),223–230 (2009).
  Medline CASGoogle Scholar
• 43  Lev-Ari S, Strier L, Kazanov D et al.: Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford)45(2),171–177 (2006).
  Medline CASGoogle Scholar
• 44  Lev-Ari S, Strier L, Kazanov D et al.: Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin. Cancer Res.11(18),6738–6744 (2005).
  Medline CASGoogle Scholar
• 45  Wang YZ, Fang XL, Li YJ, Zhang ZW, Han LM, Sha XY: preparation, characterization of paclitaxel-loaded pluronic p105 polymeric micelles and in vitro reversal of multidrug resistant tumor. Yao Xue Xue Bao43(6),640–646 (2008).
  MedlineGoogle Scholar
• 46  Ganta S, Amiji M: Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm.6(3),928–939 (2009).
  Medline CASGoogle Scholar
• 47  Jiang H, Deng CS, Zhang M, Xia J: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J. Gastroenterol.12(24),3848–3853 (2006).
  Medline CASGoogle Scholar
• 48  Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell69(7),1237–1245 (1992).
  Medline CASGoogle Scholar
• 49  Rayburn ER, Zhang R: Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov. Today13(11–12),513–521 (2008).
  Medline CASGoogle Scholar
• 50  Wang H, Yu D, Agrawal S, Zhang R: Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. Prostate54(3),194–205 (2003).
  Medline CASGoogle Scholar
• 51  Zhang Z, Zhang R: p53-independent activities of MDM2 and their relevance to cancer therapy. Curr. Cancer Drug Targets5(1),9–20 (2005).
  MedlineGoogle Scholar
• 52  Wang W, Rayburn ER, Zhao Y, Wang H, Zhang R: Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett.278(2),241–248 (2009).
  Medline CASGoogle Scholar
• 53  Chen HW, Huang HC: Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br. J. Pharmacol.124(6),1029–1040 (1998).
  Medline CASGoogle Scholar
• 54  Hermeking H, Eick D: Mediation of c-myc-induced apoptosis by p53. Science265(5181),2091–2093 (1994).
  Medline CASGoogle Scholar
• 55  Sakamuro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC: C-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene11(11),2411–2418 (1995).
  Medline CASGoogle Scholar